5OVW image
Deposition Date 2017-08-30
Release Date 2017-11-08
Last Version Date 2024-10-09
Entry Detail
PDB ID:
5OVW
Title:
Nanobody-bound BtuF, the vitamin B12 binding protein in Escherichia coli
Biological Source:
Source Organism:
Escherichia coli (Taxon ID: 562)
Lama glama (Taxon ID: 9844)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.65 Å
R-Value Free:
0.25
R-Value Work:
0.22
R-Value Observed:
0.22
Space Group:
P 21 21 21
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Vitamin B12-binding protein
Gene (Uniprot):btuF
Chain IDs:A, B, C, D, E, F
Chain Length:289
Number of Molecules:6
Biological Source:Escherichia coli
Polymer Type:polypeptide(L)
Molecule:Nanobody
Chain IDs:G, H, I, J, K, L
Chain Length:159
Number of Molecules:6
Biological Source:Lama glama
Ligand Molecules
Primary Citation
Structural basis of nanobody-mediated blocking of BtuF, the cognate substrate-binding protein of the Escherichia coli vitamin B12 transporter BtuCD.
Sci Rep 7 14296 14296 (2017)
PMID: 29084999 DOI: 10.1038/s41598-017-14512-8

Abstact

Bacterial ABC importers catalyze the uptake of essential nutrients including transition metals and metal-containing co-factors. Recently, an IgG antibody targeting the external binding protein of the Staphylococcus aureus Mn(II) ABC importer was reported to inhibit transport activity and reduce bacterial cell growth. We here explored the possibility of using alpaca-derived nanobodies to inhibit the vitamin B12 transporter of Escherichia coli, BtuCD-F, as a model system by generating nanobodies against the periplasmic binding protein BtuF. We isolated six nanobodies that competed with B12 for binding to BtuF, with inhibition constants between 10-6 and 10-9 M. Kinetic characterization of the nanobody-BtuF interactions revealed dissociation half-lives between 1.6 and 6 minutes and fast association rates between 104 and 106 M-1s-1. For the tightest-binding nanobody, we observed a reduction of in vitro transport activity of BtuCD-F when an excess of nanobody over B12 was used. The structure of BtuF in complex with the most effective nanobody Nb9 revealed the molecular basis of its inhibitory function. The CDR3 loop of Nb9 reached into the substrate-binding pocket of BtuF, preventing both B12 binding and BtuCD-F complex formation. Our results suggest that nanobodies can mediate ABC importer inhibition, providing an opportunity for novel antibiotic strategies.

Legend

Protein

Chemical

Disease

Primary Citation of related structures